Therapeutic effect of Topical Sirolimus on Facial Angiofibromas in Patients of Tuberous Sclerosis Complex

Therapeutic effect of Topical Sirolimus on Facial Angiofibromas in Patients of Tuberous Sclerosis Complex

Introduction: Tuberous sclerosis complex (TSC) is a rare autosomal dominant disorder. Facial angiofibromas are the most common cutaneous findings of TSC. Treatment modalities such as laser, surgery, and/or cryotherapy are employed. Topical therapy with Sirolimus, an mTOR inhibitor, showed beneficial...

Full description

Bibliographic Details
Main Authors: Leena HN, Savitha B Raghavan, Yogesh HR, Sujatha Sowmyanarayan, Amberkar Mohanbabu Vittalrao, Abhineetha Hosthota
Format: Article
Language:English
Published: Prathima Institute of Medical Sciences 2024-04-01
Series:Perspectives In Medical Research
Subjects:
facial angiofibroma
topical sirolimus
tuberous sclerosis complex
Online Access:https://www.pimr.org.in/2024-vol12-issue-1/originalarticle9_v1.pdf

Internet

https://www.pimr.org.in/2024-vol12-issue-1/originalarticle9_v1.pdf

Similar Items